N/A
N=4,774
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Cardiovascular Diseases
Bottom Line
View on ClinicalTrials.gov: NCT03021759 ↗Enrolled (actual)
4,774
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Statin Prescribing Rate — 40; 116; 117 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Active choice (Behavioral); Social comparison feedback (Behavioral)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Statin Prescribing Rate |
40; 116; 117 | — |
Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Eligibility Criteria
Inclusion Criteria
- Patient has a primary care physician at University of Pennsylvania Health System
- Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record
Exclusion Criteria
- Patient has an allergy or adverse reaction to statins documented in the electronic health record
- Patient has glomerular filtration rate less than 30 mL/min
- Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin
Data sourced from ClinicalTrials.gov (NCT03021759). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.